The company anticipates completing the expansion cohort for preeclampsia in the first half of 2026 and expects the interim analysis of the ReMEDy2 stroke trial based on the first 200 patients in the ...
What are the optimal measures to take in a patient with progressing stroke, or "stroke-in-evolution?" Once or twice each year, I will encounter a patient with a mild deficit upon admission who ...
In 2006, Kevin Sheth was a 27-year-old neurology resident in Boston, at both Massachusetts General Hospital and Brigham and Women’s Hospital. In that role, he did rotations within their neurology ...
According to Lin, whose research focuses on stroke recovery and rehabilitation, previous studies at UAB, like the REGARDS study, have looked at disparities regarding stroke care. This prompted him and ...
CHI Memorial is proud to announce it is the first hospital in the world to enroll a patient in a Phase 3 clinical trial evaluating a promising new treatment for ischemic stroke. This groundbreaking ...
Hosted on MSN
Volunteers sought for stroke treatment drug trials
Researchers are looking for volunteers to take part in a study to see if two medications could help prevent recurrent strokes and their negative impact on cognitive function. Royal United Hospitals ...
SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial ...
RESEARCH TRIANGLE, N.C., Oct. 22, 2025 /PRNewswire/ -- Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapy for acute ischemic ...
Please provide your email address to receive an email when new articles are posted on . In the OCEANIC-STROKE trial, asundexian met the primary efficacy and safety endpoints for secondary prevention ...
Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...
AIIMS New Delhi has led India’s first successful clinical trial of an indigenously tested advanced stroke device, a development that could significantly improve access to timely and affordable stroke ...
The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, "perispinal" etanercept—injected into the spinal area—is no more effective than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback